Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7826363rdf:typepubmed:Citationlld:pubmed
pubmed-article:7826363lifeskim:mentionsumls-concept:C0007452lld:lifeskim
pubmed-article:7826363lifeskim:mentionsumls-concept:C0225336lld:lifeskim
pubmed-article:7826363lifeskim:mentionsumls-concept:C0003483lld:lifeskim
pubmed-article:7826363lifeskim:mentionsumls-concept:C0128479lld:lifeskim
pubmed-article:7826363lifeskim:mentionsumls-concept:C1150269lld:lifeskim
pubmed-article:7826363lifeskim:mentionsumls-concept:C1441547lld:lifeskim
pubmed-article:7826363lifeskim:mentionsumls-concept:C2349975lld:lifeskim
pubmed-article:7826363lifeskim:mentionsumls-concept:C0597551lld:lifeskim
pubmed-article:7826363pubmed:issue2lld:pubmed
pubmed-article:7826363pubmed:dateCreated1995-2-16lld:pubmed
pubmed-article:7826363pubmed:abstractTextChemically synthesized human midkine enhanced plasminogen activator activity and decreased its inhibitor levels in bovine aortric endothelial cells. These activities were preserved in the C-terminal half, but not in the N-terminal half of the midkine molecule. Furthermore, a synthetic peptide of 43 amino acids designated as "C-domain", which formed the compact structure held by two disulfide bonds in the C-terminal half, mimicked intact midkine. Chemically synthesized C-domain of pleiotrophin (43 amino acids), which was 53% identical to midkine C-domain in amino acid sequence, expressed the similar activities. These 43 amino acid peptides are, so far, the shortest peptide able to enhance the fibrinolytic activities of the endothelial cells.lld:pubmed
pubmed-article:7826363pubmed:languageenglld:pubmed
pubmed-article:7826363pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7826363pubmed:citationSubsetIMlld:pubmed
pubmed-article:7826363pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7826363pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7826363pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7826363pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7826363pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7826363pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7826363pubmed:statusMEDLINElld:pubmed
pubmed-article:7826363pubmed:monthJanlld:pubmed
pubmed-article:7826363pubmed:issn0006-291Xlld:pubmed
pubmed-article:7826363pubmed:authorpubmed-author:MuramatsuTTlld:pubmed
pubmed-article:7826363pubmed:authorpubmed-author:SakakibaraSSlld:pubmed
pubmed-article:7826363pubmed:authorpubmed-author:KimuraTTlld:pubmed
pubmed-article:7826363pubmed:authorpubmed-author:AmanumaHHlld:pubmed
pubmed-article:7826363pubmed:authorpubmed-author:InuiTTlld:pubmed
pubmed-article:7826363pubmed:authorpubmed-author:KojimaSSlld:pubmed
pubmed-article:7826363pubmed:authorpubmed-author:MarutaHHlld:pubmed
pubmed-article:7826363pubmed:authorpubmed-author:MuramatsuHHlld:pubmed
pubmed-article:7826363pubmed:issnTypePrintlld:pubmed
pubmed-article:7826363pubmed:day17lld:pubmed
pubmed-article:7826363pubmed:volume206lld:pubmed
pubmed-article:7826363pubmed:ownerNLMlld:pubmed
pubmed-article:7826363pubmed:authorsCompleteYlld:pubmed
pubmed-article:7826363pubmed:pagination468-73lld:pubmed
pubmed-article:7826363pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7826363pubmed:meshHeadingpubmed-meshheading:7826363-...lld:pubmed
pubmed-article:7826363pubmed:meshHeadingpubmed-meshheading:7826363-...lld:pubmed
pubmed-article:7826363pubmed:meshHeadingpubmed-meshheading:7826363-...lld:pubmed
pubmed-article:7826363pubmed:meshHeadingpubmed-meshheading:7826363-...lld:pubmed
pubmed-article:7826363pubmed:meshHeadingpubmed-meshheading:7826363-...lld:pubmed
pubmed-article:7826363pubmed:meshHeadingpubmed-meshheading:7826363-...lld:pubmed
pubmed-article:7826363pubmed:meshHeadingpubmed-meshheading:7826363-...lld:pubmed
pubmed-article:7826363pubmed:meshHeadingpubmed-meshheading:7826363-...lld:pubmed
pubmed-article:7826363pubmed:meshHeadingpubmed-meshheading:7826363-...lld:pubmed
pubmed-article:7826363pubmed:meshHeadingpubmed-meshheading:7826363-...lld:pubmed
pubmed-article:7826363pubmed:meshHeadingpubmed-meshheading:7826363-...lld:pubmed
pubmed-article:7826363pubmed:meshHeadingpubmed-meshheading:7826363-...lld:pubmed
pubmed-article:7826363pubmed:meshHeadingpubmed-meshheading:7826363-...lld:pubmed
pubmed-article:7826363pubmed:meshHeadingpubmed-meshheading:7826363-...lld:pubmed
pubmed-article:7826363pubmed:meshHeadingpubmed-meshheading:7826363-...lld:pubmed
pubmed-article:7826363pubmed:meshHeadingpubmed-meshheading:7826363-...lld:pubmed
pubmed-article:7826363pubmed:meshHeadingpubmed-meshheading:7826363-...lld:pubmed
pubmed-article:7826363pubmed:year1995lld:pubmed
pubmed-article:7826363pubmed:articleTitleSynthetic peptides derived from midkine enhance plasminogen activator activity in bovine aortic endothelial cells.lld:pubmed
pubmed-article:7826363pubmed:affiliationLaboratory of Gene Technology and Safety, Tsukuba Life Science Center, Institute of Physical and Chemical Research (RIKEN), Ibaraki, Japan.lld:pubmed
pubmed-article:7826363pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7826363pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7826363lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7826363lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7826363lld:pubmed